Share
Hyperpigmentation — sun spots, melasma, post-inflammatory hyperpigmentation — is one of the skin concerns with the greatest impact on the perception of ageing, and at the same time one of the most poorly treated. The most common mistake: using a single depigmenting active when hyperpigmentation has multiple simultaneous active pathways requiring multiple intervention points.
The Three Steps of the Melanin Pathway
The production of visible melanin involves three stages:
- Melanin synthesis — by tyrosinase in melanocytes
- Packaging into melanosomes — inside melanocytes
- Melanosome transfer to keratinocytes — the step that makes pigmentation visible on the surface
Most depigmenting actives attack only step 1. Niacinamide attacks step 3. Combined, they interrupt two points in the process — with superior effect to either alone.
Alpha-Arbutin: The Most Potent Tyrosinase Inhibitor
Alpha-arbutin is a more effective form of regular arbutin — the same mechanism (competitive tyrosinase inhibition) but with greater potency and better stability. Without hydroquinone's adverse effects. Clinical evidence for sun spot reduction at 2% in 12 weeks.
The Brightening Serum combines alpha-arbutin at 2% + niacinamide at 5% — synthesis inhibited and transfer blocked simultaneously. Two mechanisms, one product.
Brightening Dark Spot Serum →The Third Active That Amplifies the Result
Vitamin C adds a third mechanism: neutralisation of free radicals that activate melanocytes (oxidative stress → melanogenesis activation). Morning vitamin C + evening dark spot serum + daily SPF = the three simultaneous intervention points with the most available evidence.
Timeline and Expectations
- Weeks 1–4: more even overall tone
- Weeks 4–8: reduction of more superficial spots
- Weeks 8–12+: visible reduction of deep spots or melasma
Dark spot treatment without SPF doesn't work. Mineral SPF blocks the UV that activates treated melanocytes — without it, treatment doesn't progress.
Mineral SPF50 →